P01-87 - Agomelatine as adjunctive therapy in discontinuation of long-term benzodiazepine withdrawal - 05/05/11
Résumé |
Agomelatine is a new antidepressive drug, that is successfully applied in therapy of insomnia and depression. Until now, there has been no report on its application as add-on medication in therapy for the withdrawl ob benzodiazepine.
We are reporting a case of a forty-year-old male patient who was treated with Agomelatine in lorazepam withdrawl therapy. He showed a considerabel reduction of craving as well as of insomnia and vegetative symptoms.
Therefore there is the question if the substance has its own anti-craving component and to what extent the melatonin-receptor profile is involved.
Le texte complet de cet article est disponible en PDF.Vol 26 - N° S1
P. 87 - 2011 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?